Dr. Asimakopoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3855 Health Sciences Drive
Moores Cancer Center 2308
La Jolla, CA 92093Phone+1 858-246-5223- Is this information wrong?
Summary
- Dr. Fotios Asimakopoulos is an oncologist in La Jolla, CA. He received his medical degree from School of Clinical Medicine, University of Cambridge and has been in practice 21 years. He specializes in hematologic oncology and is experienced in immunotherapy, hematologic oncology, bone marrow transplantation, multiple myeloma, and vaccine-based tumor therapy.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2009
- Brigham and Women's HospitalResidency, Internal Medicine, 1999 - 2001
- Hebrew University of JerusalemGolda Meir Fellow, Hematology, 1997 - 1999
- School of Clinical Medicine, University of CambridgeClass of 1996
- University of BristolBSc, Cellular and Molecular Pathology, First Class Honours, 1988 - 1991
Certifications & Licensure
- CA State Medical License 2011 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member American Society for Clinical Investigation, 2023
Publications & Presentations
PubMed
- 2 citationsDifferential regulation of TNFα and IL-6 expression contributes to immune evasion in prostate cancer.Ida Deichaite, Timothy J Sears, Leisa Sutton, Daniel Rebibo, Kylie Morgan, Tyler Nelson, Brent Rose, Pablo Tamayo, Napoleone Ferrara, Fotis Asimakopoulos, Hannah Carter> ;Journal of Translational Medicine. 2022 Nov 12
- 6 citationsStromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment.Athanasios Papadas, Gauri Deb, Alexander Cicala, Adam Officer, Chelsea Hope, Adam Pagenkopf, Evan Flietner, Zachary T Morrow, Philip Emmerich, Joshua Wiesner, Garrett ...> ;Cell Reports. 2022 Aug 16
- 4 citationsPonatinib sensitizes myeloma cells to MEK inhibition in the high-risk VQ model.Evan Flietner, Zhi Wen, Adhithi Rajagopalan, Oisun Jung, Lyndsay Watkins, Joshua Wiesner, Xiaona You, Yun Zhou, Yuqian Sun, Brock Kingstad-Bakke, Natalie S Callander, ...> ;Scientific Reports. 2022 Jun 23
- Join now to see all
Hospital Affiliations
- UC San Diego Medical Center - HillcrestSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: